Patents by Inventor Yong Hwa HWANG

Yong Hwa HWANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPTICAL IMAGING SYSTEM
    Publication number: 20240176111
    Abstract: An optical imaging system includes a first lens having a convex image-side surface, a second lens having a concave object-side surface, a third lens, a fourth lens, and a fifth lens disposed sequentially from an object side. The optical imaging system satisfies 4.8<f/IMG_HT<9.0, where f is a focal length of the optical imaging system, and IMG_HT is half a diagonal length of an imaging surface of an image sensor.
    Type: Application
    Filed: February 6, 2024
    Publication date: May 30, 2024
    Applicant: SAMSUNG ELECTRO-MECHANICS CO., LTD.
    Inventors: Ju Hwa SON, Jong Gi LEE, Hyo Jin HWANG, Sang Hyun JANG, Yong Joo JO
  • Optical imaging system
    Patent number: 11940599
    Abstract: An optical imaging system includes a first lens having a convex image-side surface, a second lens having a concave object-side surface, a third lens, a fourth lens, and a fifth lens disposed sequentially from an object side. The optical imaging system satisfies 4.8<f/IMG_HT<9.0, where f is a focal length of the optical imaging system, and IMG_HT is half a diagonal length of an imaging surface of an image sensor.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: March 26, 2024
    Assignee: Samsung Electro-Mechanics Co., Ltd.
    Inventors: Ju Hwa Son, Jong Gi Lee, Hyo Jin Hwang, Sang Hyun Jang, Yong Joo Jo
  • SEAT FOR VEHICLE
    Publication number: 20240092228
    Abstract: A seat for a vehicle, includes a second row center seat and a second row side seat provided on a partition wall positioned rearward of a driver seat, the second row center seat may move leftward or rightward, and an interval between the seats may be increased in a state in which the second row center seat is moved in a right direction away from the second row side seat, which makes it possible to maximally prevent body contact between a passenger in the second row center seat and a passenger in the second row side seat.
    Type: Application
    Filed: January 20, 2023
    Publication date: March 21, 2024
    Applicants: Hyundai Motor Company, Kia Corporation, Hyundai Transys Inc.
    Inventors: Jung Sang YOU, Yong Chul Kim, Dae Hee Lee, Eun Sue Kim, Jae Hoon Cho, Han Kyung Park, Jae Sung Shin, Hae Dong Kwak, Jun Sik Hwang, Gwon Hwa Bok
  • VEHICLE REAR SEAT
    Publication number: 20240067056
    Abstract: The present disclosure relates to a vehicle rear seat including: a center seat; and side seats located on the left and right of the center seat, wherein, the center seat is capable of protruding by moving the center seat forward with respect to the side seats, and in the state in which the center seat protrudes forward, it is possible to increase an inter-passenger distance so that physical contact between the passenger of the center seat and the passenger of each of the side seats can be prevented as much as possible.
    Type: Application
    Filed: March 6, 2023
    Publication date: February 29, 2024
    Inventors: Jung Sang You, Yong Chul Kim, Dae Hee Lee, Eun Sue Kim, Jae Hoon Cho, Han Kyung Park, Jae Sung Shin, Hae Dong Kwak, Jun Sik Hwang, Gwon Hwa Bok
  • Pharmaceutical composition for suppressing cell transplant rejection
    Patent number: 11191808
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting rejection of transplanted cells including a high mobility group box 1 A domain (HMGB1A) as an active ingredient. The use of the pharmaceutical composition can minimize immunological rejection, which may occur upon cell transplantation, and increase the success rate of cell transplantation.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: December 7, 2021
    Assignee: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
    Inventors: Dong Yun Lee, Yong Hwa Hwang, Min Hyung Lee
  • PHARMACEUTICAL COMPOSITION FOR SUPPRESSING CELL TRANSPLANT REJECTION
    Publication number: 20170224769
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting rejection of transplanted cells including a high mobility group box 1 A domain (HMGB1A) as an active ingredient. The use of the pharmaceutical composition can minimize immunological rejection, which may occur upon cell transplantation, and increase the success rate of cell transplantation.
    Type: Application
    Filed: May 18, 2015
    Publication date: August 10, 2017
    Applicant: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
    Inventors: Dong Yun LEE, Yong Hwa HWANG, Min Hyung LEE